Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy

BACKGROUND AND PURPOSE: Patients with recurrent cervical cancer (RecCC) who received definitive radiochemotherapy including image-guided adaptive brachytherapy (IGABT) as primary treatment are currently treated in our institution with palliative intent by chemotherapy (CHT) combined with bevacizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturdza, Alina, Hofmann, Sandra, Kranawetter, Marlene, Polterauer, Stephan, Grimm, Christoph, Krainer, Michael, Kirisits, Christian, Pötter, Richard, Reinthaller, Alexander, Schwameis, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696499/
https://www.ncbi.nlm.nih.gov/pubmed/28721510
http://dx.doi.org/10.1007/s00066-017-1178-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696499/
https://www.ncbi.nlm.nih.gov/pubmed/28721510
http://dx.doi.org/10.1007/s00066-017-1178-x

Ejemplares similares